These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Part I - Financial Information:
|
Page No.
|
||
|
Item 1 -
|
Financial Statements
|
||
|
Condensed Consolidated Balance Sheets –
September 30, 2010 and December 31, 2009
|
3
|
||
|
Condensed Consolidated Statements of Operations –
Nine and Three Months Ended September 30, 2010 and 2009
|
4
|
||
|
Condensed Consolidated Statements of Cash Flows –
Nine Months Ended September 30, 2010 and 2009
|
5
|
||
|
Notes to Condensed Consolidated Financial Statements
|
6
|
||
|
Item 2 -
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
16
|
|
|
Item 3 -
|
Quantitative and Qualitative Disclosures About Market Risk
|
18
|
|
|
Item 4 -
|
Controls and Procedures
|
18
|
|
|
Part II – Other Information:
|
|||
|
Item 1 -
|
Legal Proceedings
|
19
|
||
|
Item 1A -
|
Risk Factors
|
19
|
||
|
Item 6 -
|
Exhibits
|
19
|
||
|
Signatures
|
21
|
|||
|
Exhibit Index
|
22
|
|||
|
Exhibits
|
||||
|
Exhibit 31.1
|
||||
|
Exhibit 31.2
|
||||
|
Exhibit 32.1
|
||||
|
Exhibit 32.2
|
||||
|
September 30,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 61,082,351 | $ | 66,440,864 | ||||
|
Receivables, less allowance for doubtful accounts
|
||||||||
|
of $188,021 in 2010 and $428,074 in 2009
|
48,769,956 | 39,620,966 | ||||||
|
Inventories
|
72,004,452 | 69,974,934 | ||||||
|
Insurance receivable – asbestos
|
18,000,000 | 20,000,000 | ||||||
|
Other current assets
|
11,275,950 | 13,789,664 | ||||||
|
Total current assets
|
211,132,709 | 209,826,428 | ||||||
|
Property, plant and equipment, net
|
140,345,298 | 119,940,117 | ||||||
|
Insurance receivable - asbestos
|
87,862,580 | 95,430,060 | ||||||
|
Investments in joint ventures
|
14,400,253 | 14,867,317 | ||||||
|
Deferred tax assets
|
23,383,960 | 25,953,111 | ||||||
|
Other noncurrent assets
|
5,655,093 | 5,808,024 | ||||||
| $ | 482,779,893 | $ | 471,825,057 | |||||
|
Liabilities and Shareholders' Equity
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 18,088,209 | $ | 15,798,457 | ||||
|
Accrued payrolls and employee benefits
|
11,667,062 | 10,497,091 | ||||||
|
Industrial Revenue Bond debt
|
13,311,000 | 13,311,000 | ||||||
|
Asbestos liability – current portion
|
25,000,000 | 30,000,000 | ||||||
|
Other current liabilities
|
21,870,111 | 19,897,991 | ||||||
|
Total current liabilities
|
89,936,382 | 89,504,539 | ||||||
|
Employee benefit obligations
|
48,324,439 | 52,372,460 | ||||||
|
Asbestos liability
|
138,720,330 | 147,093,191 | ||||||
|
Other noncurrent liabilities
|
2,595,630 | 3,652,411 | ||||||
|
Total liabilities
|
279,576,781 | 292,622,601 | ||||||
|
Commitments and contingent liabilities (Note 6)
|
||||||||
|
Shareholders' equity:
|
||||||||
|
Common stock - par value $1; authorized
|
||||||||
|
20,000,000 shares; issued and outstanding
|
||||||||
|
10,246,827shares in 2010 and 10,245,927 in 2009
|
10,246,827 | 10,245,927 | ||||||
|
Additional paid-in capital
|
119,299,066 | 116,396,355 | ||||||
|
Retained earnings
|
136,379,626 | 116,804,408 | ||||||
|
Accumulated other comprehensive loss
|
(62,722,407 | ) | (64,244,234 | ) | ||||
|
Total shareholders' equity
|
203,203,112 | 179,202,456 | ||||||
| $ | 482,779,893 | $ | 471,825,057 | |||||
| Nine Months Ended September 30, |
Three Months Ended September 30,
|
| 2010 | 2009 | 2010 | 2009 | ||||||||||
|
Net sales
|
$ | 244 , 720,952 | $ | 232,694,981 | $ | 79,537,134 | $ | 71,961,129 | |||||
|
Operating costs and expenses:
|
|||||||||||||
|
Costs of products sold
|
|||||||||||||
|
(excluding depreciation)
|
168,740,339 | 157,498,251 | 56,501,918 | 47,504,103 | |||||||||
|
Selling and administrative
|
32,354,403 | 30,693,639 | 10,335,512 | 9,875,768 | |||||||||
|
Depreciation
|
6,596,206 | 5,493,962 | 2,003,471 | 1,868,158 | |||||||||
|
Gain on disposition of assets
|
(95,508 | ) | - | (389 | ) | - | |||||||
|
Total operating expenses
|
207,595,440 | 193,685,852 | 68,840,512 | 59,248,029 | |||||||||
|
Income from operations
|
37,125,512 | 39,009,129 | 10,696,622 | 12,713,100 | |||||||||
|
Other income (expense):
|
|||||||||||||
|
Investment-related income
|
1,158,786 | 1,009,636 | 1,113,274 | 862,821 | |||||||||
|
Interest expense
|
(235,771 | ) | (197,373 | ) | (81,045 | ) | (50,520 | ) | |||||
|
Other – net
|
(49,977 | ) | (1,747,743 | ) | (82,164 | ) | 565,478 | ||||||
| 873,038 | (935,480 | ) | 950,065 | 1,377,779 | |||||||||
|
Income before income taxes
|
37,998,550 | 38,073,649 | 11,646,687 | 14,090,879 | |||||||||
|
Income tax provision
|
(12,594,000 | ) | (14,247,000 | ) | (3,946,000 | ) | (5,376,000 | ) | |||||
|
Equity earnings in Chinese joint venture
|
(296,046 | ) | - | (177,026 | ) | - | |||||||
|
Net income
|
$ | 25,108,504 | $ | 23,826,649 | $ | 7,523,661 | $ | 8,714,879 | |||||
|
Net income per common share:
|
|||||||||||||
|
Basic
|
$ | 2.45 | $ | 2.34 | $ | 0.73 | $ | 0.85 | |||||
|
Diluted
|
$ | 2.44 | $ | 2.34 | $ | 0.73 | $ | 0.85 | |||||
|
Cash dividends declared per share
|
$ | 0.54 | $ | 0.54 | $ | 0.18 | $ | 0.18 | |||||
|
Weighted average number of
|
|||||||||||||
|
common shares outstanding:
|
|||||||||||||
|
Basic
|
10,246,621 | 10,189,008 | 10,246,827 | 10,204,997 | |||||||||
|
Diluted
|
10,281,510 | 10,193,350 | 10,290,669 | 10,205,633 | |||||||||
|
Nine Months Ended September 30,
|
|||||||
| 2010 | 2009 | ||||||
|
Net cash flows provided by operating activities
|
$ | 27,004,515 | $ | 44,248,761 | |||
|
Cash flows from investing activities:
|
|||||||
|
Purchases of property, plant and equipment
|
(27,676,767 | ) | (28,348,659 | ) | |||
|
Investment in Chinese joint venture
|
- | (8,820,000 | ) | ||||
|
Collateral for outstanding foreign currency exchange contracts (Note 8)
|
- | (4,326,000 | ) | ||||
|
Return of collateral for outstanding foreign currency exchange
|
|||||||
|
contracts (Note 8)
|
764,950 | 2,163,000 | |||||
|
Purchases of long-term marketable securities
|
(435,482 | ) | (780,339 | ) | |||
|
Sales of long-term marketable securities
|
408,511 | 689,104 | |||||
|
Proceeds from U.K. governmental grant
|
226,461 | - | |||||
|
Other
|
96,756 | 1,850 | |||||
|
Net cash flows used in investing activities
|
(26,615,571 | ) | (39,421,044 | ) | |||
|
Cash flows from financing activities:
|
|||||||
|
Dividends paid
|
(5,533,124 | ) | (5,499,898 | ) | |||
|
Proceeds from the issuance of common stock
|
9,731 | 568,198 | |||||
|
Excess tax benefits from the exercise of stock options
|
4,013 | 163,059 | |||||
|
Net cash flows used in financing activities
|
(5,519,380 | ) | (4,768,641 | ) | |||
|
Effect of exchange rate changes on cash and cash equivalents
|
(228,077 | ) | 1,324,176 | ||||
|
Net (decrease) increase in cash and cash equivalents
|
(5,358,513 | ) | 1,383,252 | ||||
|
Cash and cash equivalents at beginning of period
|
66,440,864 | 81,606,793 | |||||
|
Cash and cash equivalents at end of period
|
$ | 61,082,351 | $ | 82,990,045 | |||
|
Supplemental information:
|
|||||||
|
Income tax payments
|
$ | 8,092,569 | $ | 9,164,398 | |||
|
Interest payments
|
$ | 235,907 | $ | 208,549 | |||
|
Non-cash investing activities:
|
|||||||
|
Purchases of property, plant and equipment
|
|||||||
|
included in accounts payable
|
$ | 1,927,910 | $ | 2,397,033 | |||
|
1.
|
Unaudited Condensed Consolidated Financial Statements
|
|
2.
|
Inventories
|
|
(in thousands)
|
||||||||
|
September 30,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
Raw materials
|
$ | 17,917 | $ | 18,274 | ||||
|
Work-in-process
|
39,172 | 33,178 | ||||||
|
Finished goods
|
4,116 | 8,075 | ||||||
|
Supplies
|
10,799 | 10,448 | ||||||
| $ | 72,004 | $ | 69,975 | |||||
|
|
Property, plant and equipment were comprised of the following:
|
|
(in thousands)
|
||||||||
|
September 30,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
Land and land improvements
|
$ | 4,766 | $ | 4,766 | ||||
|
Buildings
|
40,149 | 31,387 | ||||||
|
Machinery and equipment
|
207,889 | 155,528 | ||||||
|
Construction-in-progress
|
10,189 | 45,188 | ||||||
|
Other
|
7,426 | 7,417 | ||||||
| 270,419 | 244,286 | |||||||
|
Accumulated depreciation
|
(130,074 | ) | (124,346 | ) | ||||
| $ | 140,345 | $ | 119,940 | |||||
|
4.
|
Other Current Liabilities
|
|
Other current liabilities were comprised of the following:
|
|
(in thousands)
|
||||||||
|
September 30,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
Customer-related liabilities
|
$ | 9,113 | $ | 10,111 | ||||
|
Foreign currency exchange contracts
|
348 | 1,171 | ||||||
|
Accrued sales commissions
|
2,308 | 1,852 | ||||||
|
Accrued income taxes payable
|
1,414 | - | ||||||
|
Dividend payable
|
1,844 | 1,844 | ||||||
|
Other
|
6,843 | 4,920 | ||||||
| $ | 21,870 | $ | 19,898 | |||||
|
(in thousands)
|
||||||||||||||||
|
Nine Months
|
Three Months
|
|||||||||||||||
|
Ended September 30,
|
Ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Balance at beginning of the period
|
$ | 4,929 | $ | 4,724 | $ | 5,289 | $ | 5,153 | ||||||||
|
Satisfaction of warranty claims
|
(1,330 | ) | (1,199 | ) | (668 | ) | (448 | ) | ||||||||
|
Provision for warranty claims
|
1,654 | 1,416 | 456 | 527 | ||||||||||||
|
Other, primarily impact from changes in foreign
|
||||||||||||||||
|
currency exchange rates
|
(56 | ) | 223 | 120 | (68 | ) | ||||||||||
|
Balance at end of the period
|
$ | 5,197 | $ | 5,164 | $ | 5,197 | $ | 5,164 | ||||||||
|
(in thousands)
|
||||||||
|
2010
|
2009
|
|||||||
|
U.S. pension benefits plans
|
$ | 5,000 | $ | 5,000 | ||||
|
U.K. pension benefits plan
|
$ | 1,060 | $ | 1,058 | ||||
|
Other postretirement benefits (e.g. net payments)
|
$ | 491 | $ | 438 | ||||
|
U.K. defined contribution plan
|
$ | 240 | $ | 200 | ||||
|
(in thousands)
|
||||||||||||||||
|
Nine Months
|
Three Months
|
|||||||||||||||
|
Ended September 30,
|
Ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
U.S. Pension Benefits
|
||||||||||||||||
|
Service cost
|
$ | 2,151 | $ | 2,099 | $ | 717 | $ | 674 | ||||||||
|
Interest cost
|
6,394 | 6,302 | 2,132 | 2,186 | ||||||||||||
|
Expected return on plan assets
|
(7,179 | ) | (7,696 | ) | (2,393 | ) | (2,651 | ) | ||||||||
|
Amortization of prior service cost
|
492 | 545 | 164 | 228 | ||||||||||||
|
Amortization of actuarial loss
|
2,613 | 1,415 | 871 | 552 | ||||||||||||
|
Net benefit cost
|
$ | 4,471 | $ | 2,665 | $ | 1,491 | $ | 989 | ||||||||
|
U.K. Pension Benefits
|
||||||||||||||||
|
Interest cost
|
$ | 1,852 | $ | 1,717 | $ | 623 | $ | 649 | ||||||||
|
Expected return on plan assets
|
(1,407 | ) | (1,094 | ) | (473 | ) | (414 | ) | ||||||||
|
Amortization of actuarial loss
|
347 | 342 | 117 | 130 | ||||||||||||
|
Net benefit cost
|
$ | 792 | $ | 965 | $ | 267 | $ | 365 | ||||||||
|
Other Postretirement Benefits
|
||||||||||||||||
|
Service cost
|
$ | 361 | $ | 317 | $ | 135 | $ | 98 | ||||||||
|
Interest cost
|
693 | 609 | 242 | 189 | ||||||||||||
|
Amortization of prior service cost
|
65 | 65 | 22 | 22 | ||||||||||||
|
Amortization of actuarial loss
|
105 | 7 | 105 | 4 | ||||||||||||
|
Net benefit cost
|
$ | 1,224 | $ | 998 | $ | 504 | $ | 313 | ||||||||
|
(in thousands)
|
|||||||||||||
|
Nine Months
|
Three Months
|
||||||||||||
|
Ended September 30,
|
Ended September 30,
|
||||||||||||
|
2010
|
2009
|
2010
|
2009
|
||||||||||
|
Net income
|
$ | 25,109 | $ | 23,827 | $ | 7,524 | $ | 8,715 | ||||||||
|
Foreign currency translation adjustments
|
(1,028 | ) | 4,045 | 2,528 | (1,299 | ) | ||||||||||
|
Unrecognized components of
|
||||||||||||||||
|
employee benefit plans
|
2,127 | 1,522 | 822 | 583 | ||||||||||||
|
Unrealized holding gains on
marketable securities
|
148 | 425 | 191 | 216 | ||||||||||||
|
Change in the fair value of derivatives
|
||||||||||||||||
|
(cash flow hedges)
|
275 | 367 | (450 | ) | (335 | ) | ||||||||||
|
Comprehensive income
|
$ | 26,631 | $ | 30,186 | $ | 10,615 | $ | 7,880 |
|
(in thousands)
|
||||||||||||||||
|
Quoted Prices in Active Markets for Identical Inputs
(Level 1)
|
Significant Other Observable Inputs
(Level 2)
|
Significant Unobservable Inputs
(Level 3)
|
Total
|
|||||||||||||
|
Investments
|
||||||||||||||||
|
Other noncurrent assets
|
$ | 2,871 | $ | - | $ | - | $ | 2,871 | ||||||||
|
Foreign currency exchange sales contracts
|
||||||||||||||||
|
Other current assets
|
- | 938 | - | 938 | ||||||||||||
|
Other noncurrent assets
|
- | 492 | - | 492 | ||||||||||||
|
Other current liabilities
|
- | 348 | - | 348 | ||||||||||||
|
Other noncurrent liabilities
|
- | 467 | - | 467 | ||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Nine Months
|
Three Months
|
|||||||||||||||
|
Ended September 30,
|
Ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Net Sales:
|
||||||||||||||||
|
Forged and Cast Rolls
|
$ | 181,273 | $ | 147,394 | $ | 59,562 | $ | 44,766 | ||||||||
|
Air and Liquid Processing
|
63,448 | 85,301 | 19,975 | 27,195 | ||||||||||||
|
Total Reportable Segments
|
$ | 244,721 | $ | 232,695 | $ | 79,537 | $ | 71,961 | ||||||||
|
Income before Income Taxes:
|
||||||||||||||||
|
Forged and Cast Rolls
|
$ | 40,570 | $ | 35,938 | $ | 11,765 | $ | 10,937 | ||||||||
|
Air and Liquid Processing
|
5,333 | 10,586 | 1,366 | 4,219 | ||||||||||||
|
Total Reportable Segments
|
45,903 | 46,524 | 13,131 | 15,156 | ||||||||||||
|
Other expense, including corporate costs
|
(7,904 | ) | (8,450 | ) | (1,484 | ) | (1,065 | ) | ||||||||
|
Total
|
$ | 37,999 | $ | 38,074 | $ | 11,647 | $ | 14,091 | ||||||||
|
Approximate open claims at end of period
|
8,262
(1)
|
|
Gross settlement and defense costs (in 000’s)
|
$ 13,044
|
|
Approximate claims settled or dismissed
|
959
|
|
(1)
|
Included as “open claims” are approximately 1,801 claims classified in various jurisdictions as “inactive” or transferred to a state or federal judicial panel on multi-district litigation, commonly referred to as the MDL.
|
|
§
|
HR&A’s interpretation of a widely accepted forecast of the population likely to have been exposed to asbestos;
|
|
§
|
epidemiological studies estimating the number of people likely to develop asbestos-related diseases;
|
|
§
|
HR&A’s analysis of the number of people likely to file an asbestos-related injury claim against the subsidiaries and the Corporation based on such epidemiological data and relevant claims history from January 1, 2006 to September 30, 2008;
|
|
§
|
an analysis of claims resolution history from January 1, 2006 to September 30, 2008 to determine the average settlement value of claims, by type of injury claimed and jurisdiction of filing; and
|
|
§
|
an adjustment for inflation in the future average settlement value of claims, at an annual inflation rate based on the Congressional Budget Office’s ten year forecast of inflation.
|
|
13.
Environmental Matters
|
|
|
|
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
(a)
|
Articles of Incorporation
|
|
|
(b)
|
By-laws
|
|
|
(a)
|
1988 Supplemental Executive Retirement Plan
|
|
|
Incorporated by reference to the Annual Report on Form 10-K for the year ended December 31, 2008.
|
|
|
(b)
|
Severance Agreements between Ampco-Pittsburgh Corporation and certain officers and employees of Ampco-Pittsburgh Corporation
|
|
|
Incorporated by reference to the Annual Report on Form 10-K for the year ended December 31, 2008.
|
|
|
(c)
|
2008 Omnibus Incentive Plan
|
|
|
Incorporated by reference to the Proxy Statement dated March 6, 2008.
|
|
|
(d)
|
Retirement and Consulting Agreement between Ampco-Pittsburgh Corporation and Ernest G. Siddons dated April 30, 2009.
|
|
|
Incorporated by reference to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009.
|
|
(31.1)
|
Certification of the principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
(31.2)
|
Certification of the principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
(32.1)
|
Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
(32.2)
|
Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
AMPCO-PITTSBURGH CORPORATION
|
|
|
DATE:
November 5, 2010
|
BY:
s/Robert A. Paul
|
|
Robert A. Paul
|
|
|
Chairman and Chief Executive Officer
|
|
|
|
|
|
DATE:
November 5, 2010
|
BY:
s/Marliss D. Johnson
|
|
Marliss D. Johnson
|
|
|
Vice President, Controller and Treasurer
|
|
|
|
|
|
Exhibit
|
(31.1)
|
Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
(31.2)
|
Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
(32.1)
|
Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
(32.2)
|
Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|